Literature DB >> 7826863

Molecular mechanisms of DNA gyrase inhibition by quinolone antibacterials.

L L Shen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7826863     DOI： 10.1016/s1054-3589(08)60550-5

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  10 in total

1.  Induction of DnaK and GroEL heat shock proteins by fluoroquinolones in Escherichia coli.

Authors:  T Mizushima; M Matsuo; K Sekimizu
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

2.  Glycosylated flavones as selective inhibitors of topoisomerase IV.

Authors:  F X Bernard; S Sablé; B Cameron; J Provost; J F Desnottes; J Crouzet; F Blanche
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.

Authors:  G Klopman; D Fercu; T E Renau; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.

Authors:  F Blanche; B Cameron; F X Bernard; L Maton; B Manse; L Ferrero; N Ratet; C Lecoq; A Goniot; D Bisch; J Crouzet
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

5.  In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.

Authors:  Oliver Langer; Martin Brunner; Markus Zeitlinger; Sophie Ziegler; Ulrich Müller; Georg Dobrozemsky; Edith Lackner; Christian Joukhadar; Markus Mitterhauser; Wolfgang Wadsak; Erich Minar; Robert Dudczak; Kurt Kletter; Markus Müller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-04       Impact factor: 9.236

6.  Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies.

Authors:  Deepti Mathpal; Mukesh Masand; Anisha Thomas; Irfan Ahmad; Mohd Saeed; Gaffar Sarwar Zaman; Mehnaz Kamal; Talha Jawaid; Pramod K Sharma; Madan M Gupta; Santosh Kumar; Swayam Prakash Srivastava; Vishal M Balaramnavar
Journal:  RSC Adv       Date:  2021-10-25       Impact factor: 4.036

7.  Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracil.

Authors:  Leonidas A Bourikas; George Kolios; Vassilis Valatas; George Notas; Ioannis Drygiannakis; Iordanis Pelagiadis; Pinelopi Manousou; Stefanos Klironomos; Ioannis A Mouzas; Elias Kouroumalis
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

8.  Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa.

Authors:  B Segatore; D Setacci; M Perilli; N Franceschini; A De Santis; F Marchetti; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

9.  Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.

Authors:  Joseph J Dajcs; Brett A Thibodeaux; Mary E Marquart; Dalia O Girgis; Mullika Traidej; Richard J O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 10.  Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities.

Authors:  Temilolu Idowu; Frank Schweizer
Journal:  Antibiotics (Basel)       Date:  2017-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.